Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2025-12-25 @ 4:36 PM
Study NCT ID:
NCT00287495
Status:
TERMINATED
Last Update Posted:
2019-12-12
First Post:
2006-02-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02-02
Start Date Type:
None
Primary Completion Date:
2012-09-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-18
Completion Date Type:
ACTUAL
First Submit Date:
2006-02-04
First Submit QC Date:
None
Study First Post Date:
2006-02-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-11
Last Update Post Date:
2019-12-12
Last Update Post Date Type:
ACTUAL